TP53 and renal carcinoma: Taken together, our results demonstrate that combined treatment with NVP-BEZ235 and curcumin has a synergistic effect on apoptosis in human renal carcinoma cells via proteasome-dependent Mcl-1 protein degradation and p53-dependent inhibition of Bcl-2 expression.